ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+11.21%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$32.7B
AUM Growth
+$4.24B
(+15%)
Cap. Flow
+$2.08B
Cap. Flow
% of AUM
6.34%
Top 10 Holdings %
Top 10 Hldgs %
24.15%
Holding
1,955
New
105
Increased
595
Reduced
1,083
Closed
168
Top Buys
| 1 |
Microsoft
MSFT
|
$187M |
| 2 |
Target
TGT
|
$184M |
| 3 |
J.M. Smucker
SJM
|
$180M |
| 4 |
Apple
AAPL
|
$173M |
| 5 |
C.H. Robinson
CHRW
|
$171M |
Top Sells
| 1 |
VF Corp
VFC
|
$133M |
| 2 |
Caterpillar
CAT
|
$41.8M |
| 3 |
Franklin Resources
BEN
|
$38.6M |
| 4 |
Air Products & Chemicals
APD
|
$34.6M |
| 5 |
Pentair
PNR
|
$33.6M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Industrials | 12.03% |
| 3 | Consumer Staples | 11.7% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Healthcare | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NKLA
1676
DELISTED
Nikola Corporation Common Stock
NKLA
| $48.3K | ﹤0.01% |
1,330
-164
| -11% | -$5.95K |
|
1677
Sutro Biopharma
STRO
$89.9M
| $47.7K | ﹤0.01% |
10,330
-1,360
| -12% | -$6.28K |
|
|
CTEV
1678
Claritev Corporation
CTEV
$1.15B
| $47.1K | ﹤0.01% |
1,112
-104
| -9% | -$4.41K |
|
1679
Solid Power
SLDP
$760M
| $47K | ﹤0.01% |
15,606
-1,454
| -9% | -$4.38K |
|
|
SLGC
1680
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $46.2K | ﹤0.01% |
18,128
-1,129
| -6% | -$2.88K |
|
1681
Tango Therapeutics
TNGX
$772M
| $45.8K | ﹤0.01% |
11,602
-1,691
| -13% | -$6.68K |
|
1682
MiMedx Group
MDXG
$1.06B
| $45.3K | ﹤0.01% |
13,281
-1,238
| -9% | -$4.22K |
|
1683
Humacyte
HUMA
$226M
| $43.5K | ﹤0.01% |
14,068
-2,025
| -13% | -$6.26K |
|
|
NGM
1684
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $42.6K | ﹤0.01% |
10,447
-1,514
| -13% | -$6.18K |
|
|
HLTH
1685
DELISTED
Cue Health Inc. Common Stock
HLTH
| $42.2K | ﹤0.01% |
23,174
-3,195
| -12% | -$5.82K |
|
1686
Xeris Biopharma Holdings
XERS
$1.27B
| $40.8K | ﹤0.01% |
+25,011
| New | +$40.8K |
|
|
PTRA
1687
DELISTED
Proterra Inc. Common Stock
PTRA
| $40K | ﹤0.01% |
26,317
-2,454
| -9% | -$3.73K |
|
|
KLRS
1688
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $39.9K | ﹤0.01% |
441
-68
| -13% | -$6.16K |
|
|
AMRN
1689
Amarin Corp
AMRN
$317M
| $39.7K | ﹤0.01% |
1,324
-336
| -20% | -$10.1K |
|
1690
Nautilus Biotechnolgy
NAUT
$83.5M
| $39.5K | ﹤0.01% |
14,268
-2,181
| -13% | -$6.04K |
|
1691
Senseonics Holdings
SENS
$373M
| $39.5K | ﹤0.01% |
55,662
-5,190
| -9% | -$3.69K |
|
1692
Gannett
GCI
$629M
| $39.2K | ﹤0.01% |
20,936
-1,853
| -8% | -$3.47K |
|
1693
Bionano Genomics
BNGO
$18.7M
| $39.1K | ﹤0.01% |
59
-5
| -8% | -$3.31K |
|
|
NPKI
1694
NPK International Inc.
NPKI
$887M
| $39.1K | ﹤0.01% |
10,153
-946
| -9% | -$3.64K |
|
1695
TETRA Technologies
TTI
$625M
| $38.8K | ﹤0.01% |
14,652
-1,366
| -9% | -$3.62K |
|
|
NVTA
1696
DELISTED
Invitae Corporation
NVTA
| $38.7K | ﹤0.01% |
28,701
-2,828
| -9% | -$3.82K |
|
1697
Clover Health Investments
CLOV
$1.41B
| $38.4K | ﹤0.01% |
45,468
-4,240
| -9% | -$3.58K |
|
1698
Inovio Pharmaceuticals
INO
$148M
| $38K | ﹤0.01% |
3,866
-504
| -12% | -$4.96K |
|
1699
Ouster
OUST
$1.59B
| $37.9K | ﹤0.01% |
4,530
+2,663
| +143% | +$22.3K |
|
|
DHC
1700
Diversified Healthcare Trust
DHC
$995M
| $37.8K | ﹤0.01% |
27,997
-2,612
| -9% | -$3.53K |
|